About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Opinion in HIV and AIDS
›
Top Articles
Current Opinion in HIV and AIDS
4.0
(top 10%)
impact factor
1.2K
(top 20%)
papers
33.6K
(top 10%)
citations
80
(top 10%)
h
-index
4.3
(top 10%)
impact factor
1.5K
all documents
36.1K
doc citations
118
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
What are biomarkers?
Current Opinion in HIV and AIDS
2010
1,450
2
Contribution of sexually transmitted infections to the sexual transmission of HIV
Current Opinion in HIV and AIDS
2010
277
3
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe
Current Opinion in HIV and AIDS
2016
274
4
HIV treatment as prevention and HPTN 052
Current Opinion in HIV and AIDS
2012
230
5
The global epidemic of HIV infection among men who have sex with men
Current Opinion in HIV and AIDS
2009
228
6
Long-acting injectable antiretrovirals for HIV treatment and prevention
Current Opinion in HIV and AIDS
2013
216
7
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
Current Opinion in HIV and AIDS
2016
191
8
Biomarkers of immune dysfunction in HIV
Current Opinion in HIV and AIDS
2010
185
9
Tissue reservoirs of HIV
Current Opinion in HIV and AIDS
2016
183
10
HIV subtype diversity worldwide
Current Opinion in HIV and AIDS
2019
182
11
HIV epidemics among transgender women
Current Opinion in HIV and AIDS
2014
176
12
The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
Current Opinion in HIV and AIDS
2011
175
13
Human papillomavirus-related disease in people with HIV
Current Opinion in HIV and AIDS
2009
167
14
Evolving epidemiology of HIV-associated malignancies
Current Opinion in HIV and AIDS
2017
164
15
The biology of CCR5 and CXCR4
Current Opinion in HIV and AIDS
2009
158
16
Role of acute and early HIV infection in the sexual transmission of HIV
Current Opinion in HIV and AIDS
2010
155
17
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
Current Opinion in HIV and AIDS
2010
155
18
HIV/hepatitis C coinfection natural history and disease progression
Current Opinion in HIV and AIDS
2011
154
19
The mucosal barrier and immune activation in HIV pathogenesis
Current Opinion in HIV and AIDS
2008
150
20
Current concepts for PrEP adherence in the PrEP revolution
Current Opinion in HIV and AIDS
2016
147
21
Epidemiology of HIV-associated tuberculosis
Current Opinion in HIV and AIDS
2009
145
22
Epidemiology and clinical characteristics of elite controllers
Current Opinion in HIV and AIDS
2011
142
23
Formulation and pharmacology of long-acting cabotegravir
Current Opinion in HIV and AIDS
2015
139
24
Th17 and regulatory T cells: implications for AIDS pathogenesis
Current Opinion in HIV and AIDS
2010
137
25
HIV-1-specific antibody responses during acute and chronic HIV-1 infection
Current Opinion in HIV and AIDS
2009
135
26
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
Current Opinion in HIV and AIDS
2010
135
27
HIV infection among female sex workers in concentrated and high prevalence epidemics
Current Opinion in HIV and AIDS
2014
134
28
Persistent HIV-1 replication during antiretroviral therapy
Current Opinion in HIV and AIDS
2016
133
29
The interplay between HIV and COVID-19: summary of the data and responses to date
Current Opinion in HIV and AIDS
2021
131
30
Fc receptor-mediated antiviral antibodies
Current Opinion in HIV and AIDS
2009
130
31
Shocking HIV out of hiding
Current Opinion in HIV and AIDS
2016
130
32
Overcoming pharmacologic sanctuaries
Current Opinion in HIV and AIDS
2013
128
33
Where does HIV hide? A focus on the central nervous system
Current Opinion in HIV and AIDS
2013
125
34
Th17 cytokines in mucosal immunity and inflammation
Current Opinion in HIV and AIDS
2010
122
35
Antiretrovirals and safer conception for HIV-serodiscordant couples
Current Opinion in HIV and AIDS
2012
122
36
Cell-to-cell HIV-1 spread and its implications for immune evasion
Current Opinion in HIV and AIDS
2009
121
37
Kaposi sarcoma herpesvirus-associated cancers and related diseases
Current Opinion in HIV and AIDS
2017
120
38
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
Current Opinion in HIV and AIDS
2015
119
39
HIV-1 entry inhibitors: an overview
Current Opinion in HIV and AIDS
2009
118
40
HIV vaccines: lessons learned and the way forward
Current Opinion in HIV and AIDS
2010
118
41
Nonhuman primate models in AIDS research
Current Opinion in HIV and AIDS
2013
118
42
The global epidemiology of adolescents living with HIV
Current Opinion in HIV and AIDS
2018
118
43
Histone deacetylase inhibitors and HIV latency
Current Opinion in HIV and AIDS
2011
116
44
The role of healthcare providers in the roll out of preexposure prophylaxis
Current Opinion in HIV and AIDS
2016
116
45
Genital inflammation, immune activation and risk of sexual HIV acquisition
Current Opinion in HIV and AIDS
2016
115
46
Th17 cell dynamics in HIV infection
Current Opinion in HIV and AIDS
2010
114
47
Concentrated HIV subepidemics in generalized epidemic settings
Current Opinion in HIV and AIDS
2014
114
48
History of passive antibody administration for prevention and treatment of infectious diseases
Current Opinion in HIV and AIDS
2015
114
49
HIV treatment cascade in MSM, people who inject drugs, and sex workers
Current Opinion in HIV and AIDS
2015
113
50
Quality and quantity
Current Opinion in HIV and AIDS
2012
112
site/software ©
exaly
; All materials licenced under
CC by-SA
.